兩連板的尚榮醫療(002551.SZ):不存在未披露或處於籌劃階段的重大事項
格隆匯 6 月 15日丨連續2個漲停的尚榮醫療(002551.SZ)發佈股票交易異常波動公告,2020年5月18日,公司召開了2020年第三次臨時股東大會,會議審議通過了《關於公司本次非公開發行A股股票方案的議案》等相關議案,截止公告披露日,公司此次非公開發行A股股票相關事項尚未向中國證監會提交申請文件,該事項最終需中國證監會審核,能否獲得中國證監會核准存在不確定性,公司將根據該事項的進展情況及時履行信息披露義務。
經查詢,公司及控股股東、實際控制人不存在關於公司的應披露而未披露的重大事項,也不存在處於籌劃階段的重大事項。
公司已於2020年4月30日披露了2020年第一季度報告,並對2020年1-6月經營業績進行了預測。2020年1-6月歸屬於上市公司股東的淨利潤區間為8133.60萬元至9218.08萬元,同比增長50%至70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.